Enanta Pharmaceuticals (ENTA) Share-based Compensation Growth (3y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -34.72% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 4.80% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 10.78% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 2.55% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 20.65% |
| 10 | Enanta Pharmaceuticals | 367.22 Mn | 203.44 Mn | - | -20.15% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -20.15% |
| Dec 31, 2025 | -18.89% |
| Sep 30, 2025 | -16.11% |
| Jun 30, 2025 | -18.10% |
| Mar 31, 2025 | -10.19% |
| Dec 31, 2024 | -2.23% |
| Sep 30, 2024 | 12.97% |
| Jun 30, 2024 | -0.35% |
| Mar 31, 2024 | 1.74% |
| Dec 31, 2023 | 18.37% |
| Sep 30, 2023 | 12.28% |
| Jun 30, 2023 | 13.75% |
| Mar 31, 2023 | 13.95% |
| Dec 31, 2022 | 11.88% |
| Sep 30, 2022 | 14.84% |
| Jun 30, 2022 | 22.22% |
| Mar 31, 2022 | 11.19% |
| Dec 31, 2021 | 1.23% |
| Sep 30, 2021 | 9.21% |
| Jun 30, 2021 | 10.80% |
| Mar 31, 2021 | 13.72% |
| Dec 31, 2020 | 5.83% |
| Sep 30, 2020 | 13.91% |
| Jun 30, 2020 | 15.30% |
| Mar 31, 2020 | 12.54% |
| Dec 31, 2019 | 15.99% |
| Sep 30, 2019 | 21.59% |
| Jun 30, 2019 | 19.02% |
| Mar 31, 2019 | 25.49% |
| Dec 31, 2018 | 43.15% |
| Sep 30, 2018 | 31.75% |
| Jun 30, 2018 | 36.46% |
| Mar 31, 2018 | 35.91% |
| Dec 31, 2017 | 58.84% |
| Sep 30, 2017 | 59.24% |
| Jun 30, 2017 | 58.71% |
| Mar 31, 2017 | 66.83% |
| Dec 31, 2016 | 108.78% |
| Sep 30, 2016 | 106.27% |
| Jun 30, 2016 | 117.82% |
| Mar 31, 2016 | 110.06% |
| Dec 31, 2015 | 92.10% |
| Sep 30, 2015 | 94.83% |
| Jun 30, 2015 | 155.47% |
| Mar 31, 2015 | 258.64% |